immatics appoints Dr Harald Stock to its Board

Tuebingen, 1 March 2011 – Immatics biotechnologies GmbH, a late-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr Harald F. Stock to the board of directors, effective February...